Drug intelligence / Profile preview

CHAMSC-101

Development stage
Unknown
Lead developer
CHA
Modality
Stem Cell Therapies → Cell Therapies
01

Overview

CHAMSC-101 is an autologous adipose-derived mesenchymal stem cell therapy being developed by CHA for reproductive medicine indications including premature ovarian insufficiency, endometrial disorders, and improvement of genetic stability of IVF oocytes. The product uses a patient's own adipose tissue-derived MSCs as the active therapeutic component and is intended to promote tissue repair and modulate local inflammation through paracrine regenerative effects rather than a single defined molecular target. Based on the provided company pipeline information, CHAMSC-101 is positioned as an early-stage cell therapy program under the Korean regenerative medicine framework, corresponding to Phase 1 level clinical development.

Other names
CHAMSC-101 adiposeCHAMSC101 adiposeCHAMSC 101 adiposeautologous adipose-derived mesenchymal stem cell therapy

Beyond the preview

Go deeper on CHAMSC-101.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHAMSC-101.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call